GlassScriptPhysician profile
Joseph Corey Allen
NPI 1861652257
$2,050.59
in general payments reported to CMS, 2019-2025
25 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $89.04 · 2021: $168 · 2022: $183 · 2023: $529 · 2024: $408 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $624.59 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $196.05 | 2019-2021 | |
| Janssen Biotech, INC. | $187.74 | 2019-2023 | |
| Boston Scientific Corporation | $165.78 | 2019-2025 | Rezum Generator |
| Urovant Sciences INC | $144.24 | 2022 | |
| Pfizer INC. | $101.84 | 2019-2025 | |
| Endo USA, INC. | $62.11 | 2025 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $59.50 | 2023 | |
| Olympus America INC. | $58.82 | 2023-2024 | Itind System |
| Laborie Medical Technologies Corp. | $47.94 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.12 | 2025 | |
| Convatec INC. | $45.06 | 2024-2025 | |
| Procept Biorobotics Corporation | $43.54 | 2023 | Aquabeam Robotic System |
| Abbvie INC. | $39.93 | 2023-2024 | Lupron Depot |
| 180 Medical, INC. | $35.19 | 2019-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $27.45 | 2025 | Tlando |
| Tempus Ai, INC | $27.11 | 2025 | Xt Cdx |
| Coloplast Corp | $24.67 | 2019 | |
| Tolmar, INC. | $22.90 | 2024 | |
| Teleflex LLC | $20.53 | 2019 | |
| Medtronic, INC. | $19.90 | 2025 | Interstim |
| Acerus Pharmaceuticals Corporation | $14.88 | 2022 | |
| Allergan, INC. | $12.83 | 2019 | |
| Mission Pharmacal Company | $11.50 | 2019 | |
| Endo Pharmaceuticals INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.